Sensorion Employee Directory
Biotechnology ResearchOccitanie, France51-200 Employees
Sensorion is a mid-sized biotechnology company based in Montpellier, Occitanie, focused on clinical-stage research and development in hearing loss disorders. The organization aims to restore, treat, and prevent hearing impairment through novel therapies. Its principal asset is SENS-401 (Arazasetron), which is moving toward a Phase 2 proof-of-concept study for cisplatin-induced ototoxicity and, in collaboration with Cochlear Limited, a trial in patients scheduled for cochlear implantation. Sensorion also pursues genetics-driven research through a strategic collaboration with the Institut Pasteur to study the genetics of hearing. It is pursuing two gene therapy programs designed to correct hereditary monogenic forms of deafness, OTOF-GT and GJB2-GT.